Introduction:
Cirrhosis is characterized by peripheral vasodilation, low arterial pressure, hyperdynamic circulatory adrenal insufficiency, and elevated cytokine production. The two causes of adrenal insufficiency in critically ill patients are depletion of the adrenal reserve and excessive stimulation of the hypothalamus-pituitary-adrenal (HPA) axis. Cirrhosis also predisposes cirrhotics to develop adrenal insufficiency. It has been documented that individuals with stable cirrhosis and liver transplant recipients, both early and later after the transplant, both have adrenal insufficiency. Low levels of cholesterol (the adrenal insufficiency source of cortisol), an increase in cytokine production that overstimulates and exhausts the hypothalamus-pituitary-adrenal axis, and the death of the adrenal glands as a result of coagulopathy are the mechanisms causing lower cortisol production in cirrhotics.
What Is the Pathophysiology Associated With Adrenal Insufficiency?
The inability of the adrenal glands to produce enough steroid hormones is known as adrenal insufficiency. In its normal state, the adrenal gland secretes androgens, mineralocorticoids, predominantly cortisol, and glucocorticoids, primarily cortisol. Blood pressure, electrolytes, and metabolism as a whole are all controlled by these hormones.
Symptoms of these hormone deficiencies are:
-
Abdominal adrenal insufficiency.
-
Vomiting.
-
Exhaustion.
-
Low blood pressure.
-
Mood swings.
-
Personality changes.
More severe cases might result in organ failure and shock (in severe cases). A severe lack of cortisol in the body can cause an adrenal crisis, which is a potentially fatal medical illness. An adrenal crisis can happen if the body is under stress from an accident, injury, surgery, or serious infection.
Adrenal insufficiency may result from the adrenal gland's own dysfunction, including destruction (such as Addison's disease), inadequate development (such as adrenal dysgenesis), or an enzyme shortage (for example - congenital adrenal hyperplasia). Adrenal insufficiency can also happen when the pituitary or hypothalamus fails to produce enough hormones necessary to control adrenal function.
What Is the Pathophysiology Associated With Adrenal Insufficiency in Patients Having Cirrhosis?
All phases of cirrhosis patients were severely ill and stable, suggesting that adrenal insufficiency is a sign of liver malfunction. It still needs to be clarified, though, exactly what causes adrenal insufficiency in the population of cirrhotics. The production of cortisol by the adrenal glands occurs whenever cortisol is required, and cholesterol is a crucial substrate for steroidogenesis. Low levels of total cholesterol, high-density lipoprotein, and low-density lipoprotein, which are associated with the severity of liver disease in cirrhotic patients, are their key characteristics. As a result, 'adrenal fatigue syndrome' results from the adrenal glands' inability to produce enough cortisol while under stress in people with cirrhosis.
Cirrhosis is characterized by elevated levels of circulating pro-inflammatory cytokines, such as tumor necrosis factor, interleukin-6, interleukin-1, and endotoxin-like lipopolysaccharide, which negatively influence the hypothalamus-pituitary axis' feedback. Pro-inflammatory cytokines contribute to decreased levels of high-density lipoprotein cholesterol via inhibition of apolipoprotein-A1 synthesis, resulting in limited delivery to the adrenal glands, and tumor necrosis factor- decreases the secretion of adrenocorticotropic hormone from the pituitary gland via completion with corticotrophin receptor and contributes to glucocorticoid deficiency. Finally, a common observation in cirrhotic patients is a prolonged prothrombin time, which can occasionally cause an adrenal hemorrhage and reduced cortisol production.
How Does Liver Disease Affect the Hpa Axis and Cortisol Metabolism?
In healthy people, cortisol secretion is non-linear and fluctuates in circadian and ultradian (60 to 90-minute cycles) patterns, with an early morning peak and nighttime low. Although decompensated cirrhosis frequently causes circadian rhythm disruption, it is unclear if this impacts cortisol secretion. Although most patients had compensated illness, a short investigation found no difference between cirrhosis patients and controls. In contrast, a smaller study found that those with cirrhosis saw a delayed peak in free plasma cortisol, with the effect being more evident in people with decompensated disease.
Cortisol metabolism is also disturbed in cirrhosis. Cortisol is shuttled between its physiologically active and inert forms by the 11 beta-hydroxysteroid dehydrogenases (11-HSD) enzyme (types 1 and 2, both found in hepatic and renal cells) (cortisone). Studies on both animals and people show that liver illness correlates with decreased levels of the 11 beta-hydroxysteroid dehydrogenases enzyme and increased levels of circulating glucocorticoids. Additionally, cirrhosis impairs cortisol elimination, which correlates with the severity of liver disease.
How Are Cirrhotic Patients With Adrenal Insufficiency Managed?
A management strategy must be properly classified according to the type of adrenal insufficiency (absolute vs. relative) and the patient's situation. With 15 to 25 milligrams of Hydrocortisone administered in two or three separate doses, early glucocorticoid replacement should be started in patients with absolute primary adrenal insufficiency (adrenal insufficiency) evidence. Uncertainty exists over the necessity of mineralocorticoid replacement therapy in cases of primary adrenal insufficiency and cirrhosis (average doses of 0.05 to 0.1 milligrams/d). Cirrhotic physiology can mimic mineralocorticoid insufficiency, and concurrent treatment of aldosterone antagonists or loop diuretics clouds the situation. In women with primary adrenal insufficiency, androgen replacement therapy is debatable and has not been thoroughly researched in cirrhosis.
In addition to administering glucocorticoids in the presence of secondary adrenal insufficiency, any associated pituitary hormone deficiency should be assessed and treated. Since adrenocorticotropic hormone does not primarily control aldosterone secretion, mineralocorticoid or androgen therapy is often unnecessary. While the degree of adrenal impairment is specific, that is the clinical condition that occurs considerably more frequently when managing adrenal insufficiency in cirrhosis.
Glucocorticoid replacement in individuals with critical illness has received much research in the general population. Current critical care and surviving sepsis camp adrenal insufficiency guidelines advise using corticosteroids in patients with septic shock who are refractory to volume resuscitation and initial vasopressor therapy due to improvements in shock resolution, vasopressor-free days, and short-term mortality. Cirrhosis treatment with hydrocortisone at the recommended stress dosage of 200 to 300 milligrams/day in three to four split doses.
Conclusion:
Assessment of the hypothalamus-pituitary-adrenal axis in cirrhotic patients is difficult. Decompensated liver illness shares a lot of symptoms with primary adrenal insufficiency, including the phenotype of exhaustion, hypotension, electrolyte imbalance, and abdominal pain. Total cortisol assays can be difficult in hypoproteinemic conditions, although abnormally elevated levels in cirrhosis are linked to poor clinical outcomes. Endocrinology-based methods for diagnosing and treating adrenal insufficiency do not take into account the physiology of the cirrhotic condition. However, it is important that the majority of adrenal insufficiency in cirrhosis serves as an independent predictor of short to medium-term mortality. Understanding the mechanisms underlying adrenal insufficiency in cirrhosis requires further study. Low total cortisol levels in the absence of consistent signs and symptoms of adrenal insufficiency do not require empiric treatment because there is often no discernible benefit to glucocorticoid replacement in common clinical circumstances. The hazards of exogenous glucocorticoids should also be considered by clinicians, including the possibility of iatrogenic cushing syndrome and the aggravation of preexisting immunodeficiency.
